Pharmaceutical companies are appealing a High Court judgement that upheld the National Institute for Health and Clinical Excellence's decision to restrict the use of anti-dementia medicines for NHS patients in the early stages of Alzheimer's disease.
Eisai and Pfizer, which are launching the appeal, say it is based on the need for greater transparency from NICE about the cost-effectiveness model used for these treatments.
At a recent AstraZeneca UK sponsored HSJ roundtable event for NHS stakeholders, I had the privilege of hearing directly from clinicians, digital leads, and operational decision-makers across multiple cancer pathways.
Around half of funding for emergency care would depend on cutting wait times and shifting care out of hospital, under detailed plans seen by HSJ.
Patient (Lived Experience) Leadership is about those affected by life-changing illness, injury or disability who want to influence change through being equal partners in decision making. In this monthly expert briefing, patient leadership champion David Gilbert picks out the most significant developments in a field of increasing relevance to the ...
HSJ is blessed with a very engaged readership. Each month our stories receive between 1,000-1,500 comments in total. This level of response is an order of magnitude greater than that enjoyed by most specialist titles.
We are aware that some of our users are experiencing problems accessing hsj.co.uk.
To protect your security as hsj.co.uk upgrades to a new platform, your existing password will no longer work.
No comments yet